The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
about
TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
P2860
The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
@en
type
label
The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
@en
prefLabel
The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
@en
P1433
P1476
The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers
@en
P2093
Brian O Bodemann
Michael A White
P304
P356
10.1016/B978-0-12-420146-0.00006-8
P478
P577
2013-11-07T00:00:00Z